{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:25:45Z","timestamp":1793780745418,"version":"4.6.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension is the largest single contributor to the global burden of disease, affecting an estimated 1.39 billion people worldwide. Clinical practice guidelines (CPGs) can aid in the effective management of this common condition, however, inconsistencies exist between CPGs, and the extent of this is unknown. Understanding the differences in CPG recommendations across income settings may provide an important means of understanding some of the global variations in clinical outcomes related to hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aims to analyse the variation between hypertension CPGs globally. It aims to assess the variation in three areas: diagnostic threshold and staging, treatment and target blood pressure (BP) recommendations in hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A search was conducted on the MEDLINE repository to identify national and international hypertension CPGs from 2010 to May 2020. An additional country-specific grey-literature search was conducted for all countries and territories of the world as identified by the World Bank. Data describing the diagnosis, staging, treatment and target blood pressure were extracted from CPGs, and variations between CPGs for these domains were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-eight CPGs from across all World Bank income settings were selected for analysis. Ninety-six per cent of guidelines defined hypertension as a clinic-based BP of \u2265140\/90\u2009mmHg, and 87% of guidelines recommended a target BP of &lt;\u2009140\/90\u2009mmHg. In the pharmacological treatment of hypertension, eight different first-step, 17 different second-step and six different third-step drug recommendations were observed. Low-income countries preferentially recommended diuretics (63%) in the first-step treatment, whilst high-income countries offered more choice between antihypertensive classes. Forty-four per cent of guidelines, of which 71% were from higher-income contexts recommended initiating treatment with dual-drug therapy at BP 160\/100\u2009mmHg or higher.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study found that CPGs remained largely consistent in the definition, staging and target BP recommendations for hypertension. Extensive variation was observed in treatment recommendations, particularly for second-line therapy. Variation existed between income settings; low-income countries prescribed cheaper drugs, offered less clinician choice in medications and initiated dual therapy at later stages than higher-income countries. Future research exploring the underlying drivers of this variation may improve outcomes for hypertensive patients across clinical contexts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-021-01963-0","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T21:12:59Z","timestamp":1620767579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Variation in hypertension clinical practice guidelines: a global comparison"],"prefix":"10.1186","volume":"19","author":[{"given":"Richu","family":"Philip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Beaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Rodriguez","family":"Gonzalvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Koldeweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia Kataria","family":"Golestaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-7746","authenticated-orcid":false,"given":"Jonathan M.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"issue":"10159","key":"1963_CR1","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"JD Stanaway","year":"2018","unstructured":"Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, Abate KH, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923\u201394. [Online] Lancet Publishing Group. https:\/\/doi.org\/10.1016\/S0140-6736(18)32225-6.","journal-title":"Lancet"},{"issue":"6","key":"1963_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control. Circulation. 2016;134(6):441\u201350. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018912. [Online] Lippincott Williams and Wilkins","journal-title":"Circulation"},{"issue":"7","key":"1963_CR3","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1016\/S2214-109X(18)30259-6","volume":"6","author":"T Beaney","year":"2018","unstructured":"Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, et al. May measurement month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6(7):e736\u201343. https:\/\/doi.org\/10.1016\/S2214-109X(18)30259-6. [Online] Elsevier Ltd","journal-title":"Lancet Glob Health"},{"issue":"10064","key":"1963_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","volume":"389","author":"B Zhou","year":"2017","unstructured":"Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants. Lancet. 2017;389(10064):37\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(16)31919-5. Accessed: 25th Aug 2020. [Online] Lancet Publishing Group","journal-title":"Lancet"},{"issue":"10022","key":"1963_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(15)01225-8. [Online] Lancet Publishing Group","journal-title":"Lancet"},{"key":"1963_CR6","doi-asserted-by":"publisher","unstructured":"Wang G, Grosse SD, Schooley MW. Conducting research on the economics of hypertension to improve cardiovascular health. Elsevier Inc.; 2017. p. S115\u2013S117. https:\/\/doi.org\/10.1016\/j.amepre.2017.08.005. [Online] American Journal of Preventive Medicine.","DOI":"10.1016\/j.amepre.2017.08.005"},{"key":"1963_CR7","volume-title":"National estimate of cost of illness for hypertension and non-persistence with drug therapy using the Medical Expenditure Panel Survey","author":"S G","year":"2011","unstructured":"S G. National estimate of cost of illness for hypertension and non-persistence with drug therapy using the Medical Expenditure Panel Survey. 2011. Available from: http:\/\/rave.ohiolink.edu\/etdc\/view?acc_num=osu1046972930. Accessed: 25th Aug 2020. [Online]."},{"issue":"6","key":"1963_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/00005650-200106000-00008","volume":"39","author":"TA Hodgson","year":"2001","unstructured":"Hodgson TA, Cai L. Medical care expenditures for hypertension, its complications, and its comorbidities. Med Care. 2001;39(6):599\u2013615. https:\/\/doi.org\/10.1097\/00005650-200106000-00008. Accessed: 25th Aug 2020. [Online] Med Care","journal-title":"Med Care"},{"issue":"4","key":"1963_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1468-0009.2007.00505.x","volume":"85","author":"G Weisz","year":"2007","unstructured":"Weisz G, Cambrosio A, Keating P, Knaapen L, Schlich T, Tournay VJ. The emergence of clinical practice guidelines. Milbank Q. 2007;85(4):691\u2013727. https:\/\/doi.org\/10.1111\/j.1468-0009.2007.00505.x. Accessed: 22nd May 2020. [Online] John Wiley & Sons, Ltd","journal-title":"Milbank Q"},{"key":"1963_CR10","doi-asserted-by":"publisher","unstructured":"Institute of Medicine. Clinical practice guidelines we can trust. National Academies Press; 2011. 15\u201317. https:\/\/doi.org\/10.17226\/13058. Accessed: 22nd May 2020. [Online] Clinical Practice Guidelines We Can Trust.","DOI":"10.17226\/13058"},{"key":"1963_CR11","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1093\/eurheartj\/ehz681","volume":"40","author":"T Mccormack","year":"2019","unstructured":"Mccormack T, Boffa RJ, Jones NR, Carville S, Mcmanus RJ. The 2018 ESC\/ESH hypertension guideline and the 2019 NICE hypertension guideline, how and why they differ. Eur Heart J. 2019;40:3456\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehz681. Accessed: 22nd May 2020. [Online]","journal-title":"Eur Heart J"},{"key":"1963_CR12","doi-asserted-by":"publisher","unstructured":"Rehan HS, Grover A, Hungin APS. Ambiguities in the guidelines for the management of arterial hypertension: Indian perspective with a call for global harmonization. Current Medicine Group LLC 1; 2017. https:\/\/doi.org\/10.1007\/s11906-017-0715-4. [Online] Current Hypertension Reports.","DOI":"10.1007\/s11906-017-0715-4"},{"key":"1963_CR13","doi-asserted-by":"publisher","unstructured":"Bakris G, Ali W, Parati G. ACC\/AHA versus ESC\/ESH on hypertension guidelines: JACC guideline comparison. Elsevier USA; 2019. 3018\u20133026. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.507. [Online] Journal of the American College of Cardiology.","DOI":"10.1016\/j.jacc.2019.03.507"},{"key":"1963_CR14","unstructured":"The World Bank. World Bank Country and Lending Groups \u2013 World Bank Data Help Desk. [Online] Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups. Accessed: 22nd May 2020."},{"key":"1963_CR15","volume-title":"National standard treatment guidelines for the primary level","author":"Afghanistan","year":"2013","unstructured":"Afghanistan. National standard treatment guidelines for the primary level. 2013."},{"key":"1963_CR16","volume-title":"Malawi Standard Treatment Guidelines (MSTG)","author":"Government of Malawi","year":"2015","unstructured":"Government of Malawi. Malawi Standard Treatment Guidelines (MSTG). 5th ed; 2015. Guidelines ( MSTG ). 2015","edition":"5"},{"key":"1963_CR17","volume-title":"Ministry of Health Sierra Leone Non-Communicable Diseases: diagnosis and treatment desk guide","author":"Ministry of Health Sierra Leone","year":"2017","unstructured":"Ministry of Health Sierra Leone. Ministry of Health Sierra Leone Non-Communicable Diseases: diagnosis and treatment desk guide. 2017."},{"key":"1963_CR18","volume-title":"Uganda Clinical Guidelines","author":"Republic of Uganda","year":"2012","unstructured":"Republic of Uganda. Uganda Clinical Guidelines. 2012."},{"key":"1963_CR19","volume-title":"National guideline for management of non communicable diseases (NCDs)","author":"Ministry of Health Rwanda","year":"2016","unstructured":"Ministry of Health Rwanda. National guideline for management of non communicable diseases (NCDs). 2016."},{"key":"1963_CR20","volume-title":"Standard treatment guidelines & national essential medicines list Tanzania mainland","author":"Government of Tanzania","year":"2017","unstructured":"Government of Tanzania. Standard treatment guidelines & national essential medicines list Tanzania mainland. 2017."},{"key":"1963_CR21","volume-title":"Hospital and referral health centre guidelines","author":"Somali Health Authorities, Word Health Organisation","year":"2015","unstructured":"Somali Health Authorities, Word Health Organisation. Hospital and referral health centre guidelines. 2015."},{"key":"1963_CR22","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.24757.06889","volume-title":"Ethiopian national guideline on Major NCDs 2016 Guidelines on Clinical and Programmatic Management of Major Non Communicable Diseases","author":"WW Dagnaw","year":"2016","unstructured":"Dagnaw WW, Yadeta D, Feleke Y, Kebede T. Ethiopian national guideline on Major NCDs 2016 Guidelines on Clinical and Programmatic Management of Major Non Communicable Diseases; 2016. https:\/\/doi.org\/10.13140\/RG.2.2.24757.06889. [Online]"},{"key":"1963_CR23","volume-title":"National guidelines for the management of hypertension in Bangladesh","author":"Directorate General of Health Services","year":"2013","unstructured":"Directorate General of Health Services. National guidelines for the management of hypertension in Bangladesh. 2013."},{"key":"1963_CR24","volume-title":"Ministry of Health Kenya National Guidelines for Cardiovascular Diseases Management Division of Non-Communicable Diseases Republic of Kenya Kenya National Guidelines for Cardiovascular Diseases Management Division of Non-Communicable Diseases","author":"Ministry of Health Kenya","year":"2018","unstructured":"Ministry of Health Kenya. Ministry of Health Kenya National Guidelines for Cardiovascular Diseases Management Division of Non-Communicable Diseases Republic of Kenya Kenya National Guidelines for Cardiovascular Diseases Management Division of Non-Communicable Diseases. 2018."},{"key":"1963_CR25","volume-title":"Standard treatment guidelines","author":"Government of India","year":"2016","unstructured":"Government of India. Standard treatment guidelines. 2016."},{"key":"1963_CR26","volume-title":"Sudan Hypertension Guideline","author":"Directorate of Non Communicable Diseases","year":"2012","unstructured":"Directorate of Non Communicable Diseases. Sudan Hypertension Guideline. 2012."},{"key":"1963_CR27","unstructured":"Association of Physicians of India. Indian guidelines of hypertension; management of hypertension. J Assoc Physicians India. 2013;61 Available from: https:\/\/www.japi.org\/february_2013_special_issue_hypertension_guidelines\/09_management_of_hypertension.pdf. Accessed: 22nd May 2020. [Online]"},{"key":"1963_CR28","volume-title":"Standard treatment guidelines, essential medicines list and essential laboratory supplies list for Zambia","author":"Republic of Zambia, Ministry of Health","year":"2017","unstructured":"Republic of Zambia, Ministry of Health. Standard treatment guidelines, essential medicines list and essential laboratory supplies list for Zambia. 2017."},{"key":"1963_CR29","volume-title":"Therapeutic Drug Guidelines Kiribati Ministry of Health","author":"Kiribati Ministry of Health","year":"2014","unstructured":"Kiribati Ministry of Health. Therapeutic Drug Guidelines Kiribati Ministry of Health. 2014."},{"key":"1963_CR30","doi-asserted-by":"publisher","unstructured":"Ibrahim MM. The Egyptian Hypertension Society Egyptian Hypertension Guidelines. Egypt Heart J. 2014:79\u2013132. https:\/\/doi.org\/10.1016\/j.ehj.2014.03.001. [Online]","DOI":"10.1016\/j.ehj.2014.03.001"},{"key":"1963_CR31","unstructured":"Kingdom of Swaziland. Standard treatment guidelines and essential medicines list of common medical conditions in the Kingdom of Swaziland."},{"key":"1963_CR32","volume-title":"7th essential medicines list and standard treatment guidelines for Zimbabwe","author":"Government of Zimbabwe","year":"2015","unstructured":"Government of Zimbabwe. 7th essential medicines list and standard treatment guidelines for Zimbabwe. 2015."},{"key":"1963_CR33","volume-title":"Cardiovascular therapeutic guidelines","author":"Fiji Ministry of Health","year":"2015","unstructured":"Fiji Ministry of Health. Cardiovascular therapeutic guidelines. 2015. Available from: http:\/\/www.health.gov.fj\/. [Online]."},{"issue":"6","key":"1963_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5830\/CVJA-2014-062","volume":"25","author":"YK Seedat","year":"2014","unstructured":"Seedat YK, Rayner BL, Veriava Y. South African hypertension practice guideline 2014. Cardiovasc J Afr. 2014;25(6):288\u201394. https:\/\/doi.org\/10.5830\/CVJA-2014-062. [Online]","journal-title":"Cardiovasc J Afr"},{"key":"1963_CR35","first-page":"1","volume-title":"Hypertension management action guide for health care providers","author":"GS Kumar","year":"2016","unstructured":"Kumar GS, O\u2019Neal JP, Davis V. Hypertension management action guide for health care providers; 2016. p. 1\u201335."},{"issue":"3","key":"1963_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5935\/abc.20160157","volume":"107","author":"MVB Malachias","year":"2016","unstructured":"Malachias MVB, Paulo C\u00e9sar Veiga Jardim PCV, Almeida FA, Lima E, Feitosa GS. 7th Brazilian Guideline of Arterial Hypertension: chapter 7 - pharmacological treatment. Arq Bras Cardiol. 2016;107(3):35\u201342. https:\/\/doi.org\/10.5935\/abc.20160157. [Online]","journal-title":"Arq Bras Cardiol"},{"key":"1963_CR37","volume-title":"Clinical practice guidelines: management of hypertension","author":"Malaysian Society of Hypertension, Ministry of Health Malaysia, Academy of Medicine of Malaysia","year":"2015","unstructured":"Malaysian Society of Hypertension, Ministry of Health Malaysia, Academy of Medicine of Malaysia. Clinical practice guidelines: management of hypertension. 2015."},{"key":"1963_CR38","volume-title":"Botswana primary care guidelines for adults","author":"Ministry of Health B","year":"2013","unstructured":"Ministry of Health B. Botswana primary care guidelines for adults. 2013."},{"key":"1963_CR39","first-page":"3","volume-title":"2015 Thai hypertension guideline","author":"P Buranakitjaroen","year":"2015","unstructured":"Buranakitjaroen P, Sitthisook S, Wataganara T, Ophascharoensuk V, Bunnag P, Roubsanthisuk W, et al. 2015 Thai hypertension guideline; 2015. p. 3."},{"key":"1963_CR40","doi-asserted-by":"publisher","unstructured":"Ministry of Health Jamaica. Guidelines for the management of hypertension. 2014;40(S4):2\u201310. https:\/\/doi.org\/10.1016\/S1138-3593(14)74391-6.","DOI":"10.1016\/S1138-3593(14)74391-6"},{"issue":"3","key":"1963_CR41","first-page":"9","volume":"8","author":"F Noohi","year":"2012","unstructured":"Noohi F, Sarrafzadegan N, Khosravi A, Andalib E. The first Iranian recommendations on prevention, evaluation and management of high blood pressure. ARYA Atheroscler. 2012;8(3):9.","journal-title":"ARYA Atheroscler"},{"issue":"8","key":"1963_CR42","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/HJH.0000000000001418","volume":"35","author":"E Barbosa","year":"2017","unstructured":"Barbosa E, Coca A, Lopez-Jaramillo P, Ramirez AJ, Sanchez RA, Zanchetti A. Guidelines on the management of arterial hypertension and related comorbidities in Latin America. J Hypertens. 2017;35(8):1529\u201345. https:\/\/doi.org\/10.1097\/HJH.0000000000001418. [Online]","journal-title":"J Hypertens"},{"issue":"3","key":"1963_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.11909\/j.issn.1671-5411.2019.03.014","volume":"16","author":"LS Liu","year":"2019","unstructured":"Liu LS, Wu ZS, Wang JG, Wang W, Bao YJ, Cai J, et al. 2018 Chinese guidelines for prevention and treatment of hypertension\u2014a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182\u2013245. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2019.03.014. [Online]","journal-title":"J Geriatr Cardiol"},{"issue":"2","key":"1963_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.11909\/j.issn.1671-5411.2019.02.001","volume":"16","author":"Q Hua","year":"2019","unstructured":"Hua Q, Fan L. 2019 Chinese guideline for the management of hypertension in the elderly. J Geriatr Cardiol. 2019;16(2):67\u201399. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2019.02.001. [Online]","journal-title":"J Geriatr Cardiol"},{"key":"1963_CR45","doi-asserted-by":"publisher","unstructured":"Rabi DM, Mcbrien KA, Sapir-pichhadze R, Nakhla M, Ahmed B, Dumanski SM, et al. Hypertension Canada\u2019s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. 2020;36:596\u2013624. https:\/\/doi.org\/10.1016\/j.cjca.2020.02.086.","DOI":"10.1016\/j.cjca.2020.02.086"},{"key":"1963_CR46","volume-title":"New Zealand 2018- CVD guidelines","author":"Ministry of Health NZ","year":"2018","unstructured":"Ministry of Health NZ. New Zealand 2018- CVD guidelines. 2018."},{"key":"1963_CR47","volume-title":"Saudi hypertension guidelines 2018, Saudi Hypertension Management Society","author":"Saudi Hypertension","year":"2018","unstructured":"Saudi Hypertension. Saudi hypertension guidelines 2018, Saudi Hypertension Management Society. 2018."},{"key":"1963_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5694\/mja16.00526","volume-title":"Guideline for the diagnosis and management of hypertension in adults\u20142016","author":"GM Gabb","year":"2016","unstructured":"Gabb GM, Mangoni A, Anderson CS, Cowley D, Dowden JS, Golledge J, et al. Guideline for the diagnosis and management of hypertension in adults\u20142016; 2016. p. 85\u20139. https:\/\/doi.org\/10.5694\/mja16.00526."},{"key":"1963_CR49","volume-title":"Hypertension in adults: diagnosis and 5 management","author":"National Institute for Health and Care Excellence","year":"2019","unstructured":"National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and 5 management. 2019. Available from: https:\/\/www.nice.org.uk\/guidance\/ng136\/documents\/draft-guideline. Accessed: 22nd May 2020. [Online]."},{"issue":"1","key":"1963_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40292-014-0074-z","volume":"22","author":"MH El-Deeb","year":"2015","unstructured":"El-Deeb MH, Sulaiman KJ, Al-Riyami AA, Mohsin N, Al-Mukhaini M, Al-Lamki M, et al. 2015 Oman Heart Association Guidelines for the Management of Hypertension: practical recommendations from the Oman Heart Association (OHA). High Blood Press Cardiovasc Prev. 2015;22(1):83\u201397. https:\/\/doi.org\/10.1007\/s40292-014-0074-z. [Online]","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"1963_CR51","doi-asserted-by":"publisher","unstructured":"Tay JC, Sule AA, Chew D, Tey J, Lau T, Lee S, et al. Ministry of Health Clinical Practice Guidelines: hypertension. 2018;59(1):17\u201327. https:\/\/doi.org\/10.11622\/smedj.2018007.","DOI":"10.11622\/smedj.2018007"},{"issue":"1","key":"1963_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40885-019-0124-x","volume":"25","author":"H-Y Lee","year":"2019","unstructured":"Lee H-Y, Shin J, Kim G-H, Park S, Ihm S-H, Kim HC, et al. 2018 Korean Society of Hypertension Guidelines for the Management of Hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25(1):1\u201324. https:\/\/doi.org\/10.1186\/s40885-019-0124-x. [Online] Clinical Hypertension","journal-title":"Clin Hypertens"},{"issue":"July","key":"1963_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1049\/oap-cired.2017.1227","volume":"2017","author":"Energy R, Development S, Independent Electricity System Operator I, Republic of Malawi, Manual CC, RSA Grid Code Secretariat","year":"2014","unstructured":"Energy R, Development S, Independent Electricity System Operator I, Republic of Malawi, Manual CC, RSA Grid Code Secretariat, et al. Brunei Darussalam National Hypertension Guideline. CIRED Open Access Proc J. 2014;2017(July):1\u201367. https:\/\/doi.org\/10.1049\/oap-cired.2017.1227. [Online]","journal-title":"CIRED Open Access Proc J"},{"issue":"9","key":"1963_CR54","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235\u2013481. https:\/\/doi.org\/10.1038\/s41440-019-0284-9. [Online] Springer US","journal-title":"Hypertens Res"},{"key":"1963_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/HYP.0000000000000065","volume-title":"Clinical Practice Guideline 2017 ACC \/ AHA \/ AAPA \/ ABC \/ ACPM \/ AGS \/ APhA \/ ASH \/ ASPC \/ NMA \/ PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. Clinical Practice Guideline 2017 ACC \/ AHA \/ AAPA \/ ABC \/ ACPM \/ AGS \/ APhA \/ ASH \/ ASPC \/ NMA \/ PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology; 2018. p. 13\u2013115. https:\/\/doi.org\/10.1161\/HYP.0000000000000065. [Online]"},{"key":"1963_CR56","doi-asserted-by":"publisher","unstructured":"Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Oxford University Press; 2018. 3021\u20133104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339. [Online] European Heart Journal.","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"1963_CR57","doi-asserted-by":"publisher","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). American Medical Association; 2014. 507\u2013520. https:\/\/doi.org\/10.1001\/jama.2013.284427. [Online] JAMA - Journal of the American Medical Association.","DOI":"10.1001\/jama.2013.284427"},{"issue":"3","key":"1963_CR58","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5603\/KP.2017.0055","volume":"75","author":"D Czarnecka","year":"2017","unstructured":"Czarnecka D, Jankowski P, Kopec G, Pajak A, Podolec J, Zdrojewski T, et al. Polish forum for prevention guidelines on hypertension: update 2017. Kardiol Pol. 2017;75(3):282\u20135. https:\/\/doi.org\/10.5603\/KP.2017.0055. [Online]","journal-title":"Kardiol Pol"},{"issue":"1","key":"1963_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcma.2014.11.005","volume":"78","author":"C Chiang","year":"2015","unstructured":"Chiang C, Wang T, Ueng K, Lin T, Yeh H, Chen C, et al. ScienceDirect 2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension. J Chin Med Assoc. 2015;78(1):1\u201347. https:\/\/doi.org\/10.1016\/j.jcma.2014.11.005. [Online] Elsevier Taiwan LLC and the Chinese Medical Association","journal-title":"J Chin Med Assoc"},{"issue":"3","key":"1963_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.6515\/ACS20170421A","volume":"33","author":"CE Chiang","year":"2017","unstructured":"Chiang CE, Wang TD, Lin TH, Yeh HI, Liu PY, Cheng HM, et al. The 2017 focused update of the guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the management of hypertension. Acta Cardiol Sin. 2017;33(3):213\u201325. https:\/\/doi.org\/10.6515\/ACS20170421A. [Online]","journal-title":"Acta Cardiol Sin"},{"key":"1963_CR61","unstructured":"Protocols P. Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care Settings Revised Edition December 2018."},{"issue":"1","key":"1963_CR62","doi-asserted-by":"publisher","first-page":"64","DOI":"10.12809\/hkmj187701","volume":"25","author":"MK Lim","year":"2019","unstructured":"Lim MK, Ha SCN, Luk KH, Yip WK, Tsang CSH, Wong MCS. Update on the Hong Kong reference framework for hypertension care for adults in primary care settings\u2014review of evidence on the definition of high blood pressure and goal of therapy. Hong Kong Med J. 2019;25(1):64\u20137. https:\/\/doi.org\/10.12809\/hkmj187701. [Online]","journal-title":"Hong Kong Med J"},{"issue":"1","key":"1963_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/fcp.12044","volume":"28","author":"J Blacher","year":"2014","unstructured":"Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B, et al. Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam Clin Pharmacol. 2014;28(1):1\u20139. https:\/\/doi.org\/10.1111\/fcp.12044. [Online]","journal-title":"Fundam Clin Pharmacol"},{"issue":"5","key":"1963_CR64","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5935\/abc.20170165","volume":"109","author":"GMM de Oliveira","year":"2017","unstructured":"de Oliveira GMM, Mendes M, Malachias MVB, Morais J, Moreira Filho O, Coelho AS, et al. 2017 guidelines for arterial hypertension management in primary health care in Portuguese language countries. Arq Bras Cardiol. 2017;109(5):389\u201396. https:\/\/doi.org\/10.5935\/abc.20170165. [Online]","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"1963_CR65","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","volume":"38","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982\u20131004. https:\/\/doi.org\/10.1097\/HJH.0000000000002453. [Online]","journal-title":"J Hypertens"},{"issue":"22","key":"1963_CR66","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"22","author":"JT Wright","year":"2015","unstructured":"Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;22(22):2103\u201319. https:\/\/doi.org\/10.1056\/NEJMoa1511939. [Online]","journal-title":"N Engl J Med"},{"key":"1963_CR67","doi-asserted-by":"publisher","unstructured":"Yaria J, Makanjuola T, Yaya S, Kaczorowski J. Gaps in hypertension guidelines in low- and middle income versus high income countries: a systematic review. 2017;68(6):1328\u201337. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.08290.Gaps.","DOI":"10.1161\/HYPERTENSIONAHA.116.08290.Gaps"},{"key":"1963_CR68","doi-asserted-by":"publisher","unstructured":"Khera R, Lu Y, Lu J, Saxena A, Nasir K, Jiang L, et al. Impact of 2017 ACC\/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. BMJ (Online). 2018;362 https:\/\/doi.org\/10.1136\/bmj.k2357. [Online] BMJ Publishing Group","DOI":"10.1136\/bmj.k2357"},{"issue":"12","key":"1963_CR69","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2471\/BLT.19.234500","volume":"97","author":"M Dubey","year":"2019","unstructured":"Dubey M, Rastogi S, Awasthi A. Hypertension prevalence as a function of different guidelines, India. Bull World Health Organ. 2019;97(12):799\u2013809. https:\/\/doi.org\/10.2471\/BLT.19.234500. [Online] World Health Organization","journal-title":"Bull World Health Organ"},{"issue":"1","key":"1963_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/NEJM200101043440101","volume":"344","author":"FM Sacks","year":"2001","unstructured":"Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001;344(1):3\u201310. https:\/\/doi.org\/10.1056\/NEJM200101043440101. [Online] N Engl J Med","journal-title":"N Engl J Med"},{"key":"1963_CR71","doi-asserted-by":"publisher","unstructured":"Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc; 2013. https:\/\/doi.org\/10.1161\/JAHA.112.004473. [Online] Journal of the American Heart Association.","DOI":"10.1161\/JAHA.112.004473"},{"key":"1963_CR72","doi-asserted-by":"publisher","unstructured":"JE S, A LG, JS C. Exercise and cardiovascular risk in patients with hypertension. Am J Hypertens. 2015;28(2) https:\/\/doi.org\/10.1093\/AJH\/HPU191. [Online] Am J Hypertens","DOI":"10.1093\/AJH\/HPU191"},{"key":"1963_CR73","doi-asserted-by":"publisher","unstructured":"Wright JM, Musini VM, Gill R. First-line drugs for hypertension. John Wiley and Sons Ltd; 2018. https:\/\/doi.org\/10.1002\/14651858.CD001841.pub3. Accessed: 14th Oct 2020. [Online] Cochrane Database of Systematic Reviews.","DOI":"10.1002\/14651858.CD001841.pub3"},{"key":"1963_CR74","doi-asserted-by":"publisher","unstructured":"Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. John Wiley and Sons Ltd; 2017. https:\/\/doi.org\/10.1002\/14651858.CD002003.pub5. Accessed: 14th Oct 2020. [Online] Cochrane Database of Systematic Reviews.","DOI":"10.1002\/14651858.CD002003.pub5"},{"issue":"25","key":"1963_CR75","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1901113","volume":"380","author":"DB Ojji","year":"2019","unstructured":"Ojji DB, Mayosi B, Francis V, Badri M, Cornelius V, Smythe W, et al. Comparison of dual therapies for lowering blood pressure in Black Africans. N Engl J Med. 2019;380(25):2429\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1901113. Accessed: 25th August 2020. [Online] Massachusetts Medical Society","journal-title":"N Engl J Med"},{"issue":"9","key":"1963_CR76","doi-asserted-by":"publisher","first-page":"502","DOI":"10.5694\/j.1326-5377.2002.tb04920.x","volume":"177","author":"CM Farquhar","year":"2002","unstructured":"Farquhar CM, Kofa EW, Slutsky JR. Clinicians\u2019 attitudes to clinical practice guidelines: a systematic review. Med J Aust. 2002;177(9):502\u20136. https:\/\/doi.org\/10.5694\/j.1326-5377.2002.tb04920.x. Accessed: 22nd May 2020. [Online] John Wiley & Sons, Ltd","journal-title":"Med J Aust"},{"issue":"1","key":"1963_CR77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-12-26","volume":"12","author":"T Wisl\u00f8ff","year":"2012","unstructured":"Wisl\u00f8ff T, Selmer RM, Halvorsen S, Fretheim A, Norheim OF, Kristiansen IS. Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - a cost-effectiveness analysis. BMC Cardiovasc Disord. 2012;12(1):26. https:\/\/doi.org\/10.1186\/1471-2261-12-26. Accessed: 22nd May 2020. [Online] BioMed Central","journal-title":"BMC Cardiovasc Disord"},{"key":"1963_CR78","unstructured":"BNF: British National Formulary - NICE. Atenolol; medicinal forms. [Online] NICE; Available from: https:\/\/bnf.nice.org.uk\/medicinal-forms\/atenolol.html. Accessed: 22nd May 2020."},{"key":"1963_CR79","doi-asserted-by":"publisher","unstructured":"Guerrero-Garc\u00eda C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Bioexcel Publishing LTD; 2018. https:\/\/doi.org\/10.7573\/dic.212531. [Online] Drugs in Context.","DOI":"10.7573\/dic.212531"},{"key":"1963_CR80","doi-asserted-by":"publisher","unstructured":"Guerrero-Garc\u00eda C, Rubio-Guerra AF, Online A. Drugs in context rigorous \u2022 rapid \u2022 responsive review citation combination therapy in the treatment of hypertension. https:\/\/doi.org\/10.7573\/dic.212531.","DOI":"10.7573\/dic.212531"},{"issue":"28","key":"1963_CR81","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159\u2013219. https:\/\/doi.org\/10.1093\/eurheartj\/eht151. Accessed: 24th Feb 2021. [Online] Oxford Academic","journal-title":"Eur Heart J"},{"key":"1963_CR82","volume-title":"Hypertension: clinical management of primary hypertension in adults","author":"National Institute for Health and Care Excellence","year":"2011","unstructured":"National Institute for Health and Care Excellence. Hypertension: clinical management of primary hypertension in adults. 2011. Available from: www.nice.org.uk\/guidance\/CG34. Accessed: 24th Feb 2021. [Online]."},{"key":"1963_CR83","doi-asserted-by":"publisher","unstructured":"Agarwal R. Implications of blood pressure measurement technique for implementation of Systolic Blood Pressure Intervention Trial (SPRINT). J Am Heart Assoc. 2017;6(2) https:\/\/doi.org\/10.1161\/JAHA.116.004536. Accessed: 24th Feb 2021. [Online] John Wiley and Sons Inc","DOI":"10.1161\/JAHA.116.004536"},{"key":"1963_CR84","doi-asserted-by":"publisher","unstructured":"Saiz LC, Gorricho J, Garj\u00f3n J, Celaya MC, Muruz\u00e1bal L, del Mal\u00f3n MM, et al. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database Syst Rev. 2017;2017(10). https:\/\/doi.org\/10.1002\/14651858.CD010315.pub2. [Online] John Wiley and Sons Ltd.","DOI":"10.1002\/14651858.CD010315.pub2"},{"issue":"7","key":"1963_CR85","doi-asserted-by":"publisher","first-page":"CD010315","DOI":"10.1002\/14651858.CD010315.pub3","volume":"7","author":"LC Saiz","year":"2018","unstructured":"Saiz LC, Gorricho J, Garj\u00f3n J, Celaya MC, Erviti J, Leache L. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database Syst Rev. 2018;7(7):CD010315. https:\/\/doi.org\/10.1002\/14651858.CD010315.pub3. Accessed: 24th Feb 2021. [Online] John Wiley & Sons, Ltd","journal-title":"Cochrane Database Syst Rev"},{"key":"1963_CR86","doi-asserted-by":"publisher","unstructured":"Saiz LC, Gorricho J, Garj\u00f3n J, Celaya MC, Erviti J, Leache L. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. John Wiley and Sons Ltd; 2020. https:\/\/doi.org\/10.1002\/14651858.CD010315.pub4. Accessed: 24th Feb 2021. [Online] Cochrane Database of Systematic Reviews.","DOI":"10.1002\/14651858.CD010315.pub4"},{"key":"1963_CR87","doi-asserted-by":"publisher","unstructured":"Garrison SR, Kolber MR, Korownyk CS, Mccracken RK, Heran BS, Allan GM. Blood pressure targets for hypertension in older adults. Cochrane Database Syst Rev. 2017;2017(8) https:\/\/doi.org\/10.1002\/14651858.CD011575.pub2. [Online] John Wiley and Sons Ltd","DOI":"10.1002\/14651858.CD011575.pub2"},{"issue":"1","key":"1963_CR88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.STR.20.1.4","volume":"20","author":"HM Perry","year":"1989","unstructured":"Perry HM, Smith WMF, McDonald RH, Black D, Cutler JA, Furberg CD, et al. Morbidity and mortality in the systolic hypertension in the elderly program (SHEP) pilot study. Stroke. 1989;20(1):4\u201313. https:\/\/doi.org\/10.1161\/01.STR.20.1.4. [Online] Stroke","journal-title":"Stroke"},{"issue":"8","key":"1963_CR89","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jama.2009.205","volume":"301","author":"P Tricoci","year":"2009","unstructured":"Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC. Scientific evidence underlying the ACC\/AHA clinical practice guidelines. JAMA - J Am Med Assoc. 2009;301(8):831\u201341. https:\/\/doi.org\/10.1001\/jama.2009.205. [Online] American Medical Association","journal-title":"JAMA - J Am Med Assoc"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-01963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-01963-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-01963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T21:13:58Z","timestamp":1620767638000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-01963-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1963"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-01963-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This evaluation of publicly available information was deemed by the research and innovation office of Imperial College London to not require formal ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NP has co-authored previous national and international hypertension guidelines, including ISH 2020. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}